Bicillin L-A 1.2 million unit prefilled syringe for injection remains in shortage until 31 March 2027.
Bicillin L-A 600,000 unit prefilled syringe for injection remains unavailable until 30 November 2027.
Overseas-registered benzathine benzylpenicillin products that are subsidised through the PBS remain available to support continued patient access.
Health professionals should consider reserving any remaining australian-registered stock for paediatric patients and using the overseas-registered benzathine benzylpenicillin products for all other patients, in line with the approved indications.
